Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Platelet-rich plasma may help with hair growth and skin quality but more research is needed to confirm its effectiveness.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Platelet-rich plasma injections can effectively treat male pattern hair loss, improving hair density and quality with high patient satisfaction.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Different processes create patterns in skin and things like hair and feathers.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.